Tel. (502) 558-9209

Myocardial Assist Systems and Technology, LLC
620 S. Third St.
Suite 205
Louisville, KY 40202

Expanding & Improving Cardiac Assist Devices

Heart failure—or congestive heart failure—affects the lives of more than 5 million Americans, with more than 550,000 new cases diagnosed each year. Along with heart disease, heart failure is the leading causes of death in both men and women. As the U.S. population ages over the next five years, between 15 to 20 million Americans are expected to be diagnosed with heart failure—far surpassing breast, prostate, and colon cancers in annual diagnosis and mortality.

However—with continued research and development of state-of-the-art myocardial assist devices—there is hope that more and more heart patients can live longer, better lives. Ventricular assist devices (VADs) are essential bridges to transplant for patients with end-stage congestive heart failure. More recently, VADs have also become long-term solutions for heart patients who have no hope for a transplant.

Dr. Mark Slaughter

Longer Higher-Quality-of-Living

Myocardial Assist Systems and Technology, LLC (MAST) is committed to the effort of continually developing and improving the high-tech assist devices that cardiac surgeons so desparately need in their fight to save lives.

Led by Dr. Mark Slaughter, a nationally-recognized Chicago cardiothoracic surgeon, experienced researcher, and the current Director of Heart Transplantation and Mechanical Assist Device Program at Advocate Christ Medical Center in Oak Lawn, Illinois, MAST specializes in device technology related to heart surgery, cardiac assist, LVADs, and other cardiac / thorasic assist devices, with services encompassing:

Myocardial Assist Device Clinical Trials



	Home \| Our Team \| Our Services \| Publications & Presentations \| Contact Us
Tel. (502) 558-9209 Myocardial Assist Systems and Technology, LLC 620 S. Third St. Suite 205 Louisville, KY 40202	Expanding & Improving Cardiac Assist Devices Heart failure—or congestive heart failure—affects the lives of more than 5 million Americans, with more than 550,000 new cases diagnosed each year. Along with heart disease, heart failure is the leading causes of death in both men and women. As the U.S. population ages over the next five years, between 15 to 20 million Americans are expected to be diagnosed with heart failure—far surpassing breast, prostate, and colon cancers in annual diagnosis and mortality. However—with continued research and development of state-of-the-art myocardial assist devices—there is hope that more and more heart patients can live longer, better lives. Ventricular assist devices (VADs) are essential bridges to transplant for patients with end-stage congestive heart failure. More recently, VADs have also become long-term solutions for heart patients who have no hope for a transplant.
	Longer Higher-Quality-of-Living Myocardial Assist Systems and Technology, LLC (MAST) is committed to the effort of continually developing and improving the high-tech assist devices that cardiac surgeons so desparately need in their fight to save lives. Led by Dr. Mark Slaughter, a nationally-recognized Chicago cardiothoracic surgeon, experienced researcher, and the current Director of Heart Transplantation and Mechanical Assist Device Program at Advocate Christ Medical Center in Oak Lawn, Illinois, MAST specializes in device technology related to heart surgery, cardiac assist, LVADs, and other cardiac / thorasic assist devices, with services encompassing:
Copyright © 2008-2009. Myocardial Assist Systems and Technology, LLC. Site designed by Caroline Andrew & Associates, LLC Home \| Disclaimer \| Privacy Policy \| Contact Us